Xenon and Genentech Partner to Develop Pain Therapeutics and Companion Diagnostics
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 2 (Table of Contents)
Published: 10 Feb-2012
DOI: 10.3833/pdr.v2012.i2.1678 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Canadian Xenon Pharmaceuticals has formed its sixth major partnership by agreeing to collaborate with Roche’s Genentech on the discovery and development of novel compounds and companion diagnostics for the potential treatment of pain...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS